Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Golimumab

Brand: Simponi®
NICE TA: 225
Indication: Rheumatoid arthritis, 2nd line after the failure of a TNF inhibitor (NICE TA225) and (LMMG RA Biologic Pathway)
Disease category: Musculoskeletal and joint disease
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Treatment to be continued with the most cost effective, clinically appropriate drug (taking into account administration costs, required dose and product price per dose). This may need to be varied in individual cases due to differences in the mode of administration and treatment schedules.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red